We use cookies to provide you with a better experience. If you continue to use this site, we'll assume you're happy with this. Alternatively, click here to find out how to manage these cookies

hide cookie message
Thomson Reuters improves access to biological research data

Thomson Reuters improves access to biological research data

Users will no longer have to manually collate data from different sources

Article comments

Thomson Reuters is improving the way researchers can access and manage content in its biological science database, with a new data management, analytics and modelling system.

The company is using the IDBS ScienceLink scientific content brokerage platform, which will replace a process that required users to manually collate information from different sources.

ScienceLink, a feature of IDBS’ E-WorkBook enterprise electronic laboratory notebook, allows customers to launch a single query to search and retrieve data from internal systems and from other licensed, external scientific data sources.

Thomson Reuters said the combined solution will accelerate biological research in areas such as target identification and validation, experimental pharmacology, toxicology and biomarker discovery.

“Biology is an important research area for our customers and we are working to gather and deliver the highest quality and most relevant scientific content across the R&D lifecycle, to help organisations speed innovation and deliver actionable insights and results,” said Joseph Donahue, senior vice president of global sales at Thomson Reuters.

In other Thomson Reuters news, the content and financial information firm last month proposed a number of changes to the financial codes in its feeds in response to competition concerns, but it was informed by Europe's top antitrust official that the modifications were not enough.

EU competition commissioner Joaquin Almunia said that following market testing, he was unconvinced that Thomson Reuters was making it easy enough for customers to use alternative providers. The long-running competition case had now reached "a critical stage", he said.

Share:

Comments

Advertisement
Advertisement
Send to a friend

Email this article to a friend or colleague:


PLEASE NOTE: Your name is used only to let the recipient know who sent the story, and in case of transmission error. Both your name and the recipient's name and address will not be used for any other purpose.


ComputerworldUK Knowledge Vault

ComputerworldUK
Share
x
Open
* *